Literature DB >> 24275142

"Drinking in the dark" (DID) procedures: a model of binge-like ethanol drinking in non-dependent mice.

Todd E Thiele1, Montserrat Navarro2.   

Abstract

This review provides an overview of an animal model of binge-like ethanol drinking that has come to be called "drinking in the dark" (DID), a procedure that promotes high levels of ethanol drinking and pharmacologically relevant blood ethanol concentrations (BECs) in ethanol-preferring strains of mice. Originally described by Rhodes, Best, Belknap, Finn, and Crabbe (2005), the most common variation of the DID procedure, using singly housed mice, involves replacing the water bottle with a bottle containing 20% ethanol for 2-4 h, beginning 3 h into the dark cycle. Using this procedure, high ethanol drinking strains of mice (e.g., C57BL/6J) typically consume enough ethanol to achieve BECs greater than 100 mg/dL and to exhibit behavioral evidence of intoxication. This limited access procedure takes advantage of the time in the animal's dark cycle in which the levels of ingestive behaviors are high, yet high ethanol intake does not appear to stem from caloric need. Mice have the choice of drinking or avoiding the ethanol solution, eliminating the stressful conditions that are inherent in other models of binge-like ethanol exposure in which ethanol is administered by the experimenter, and in some cases, potentially painful. The DID procedure is a high throughput approach that does not require extensive training or the inclusion of sweet compounds to motivate high levels of ethanol intake. The high throughput nature of the DID procedure makes it useful for rapid screening of pharmacological targets that are protective against binge-like drinking and for identifying strains of mice that exhibit binge-like drinking behavior. Additionally, the simplicity of DID procedures allows for easy integration into other paradigms, such as prenatal ethanol exposure and adolescent ethanol drinking. It is suggested that the DID model is a useful tool for studying the neurobiology and genetics underlying binge-like ethanol drinking, and may be useful for studying the transition to ethanol dependence.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Binge-like; Blood–ethanol; Dependence; Drinking-in-the-dark; Ethanol; Intoxication

Mesh:

Substances:

Year:  2013        PMID: 24275142      PMCID: PMC4004717          DOI: 10.1016/j.alcohol.2013.08.005

Source DB:  PubMed          Journal:  Alcohol        ISSN: 0741-8329            Impact factor:   2.405


  62 in total

Review 1.  Gene targeting: technical confounds and potential solutions in behavioral brain research.

Authors:  R Gerlai
Journal:  Behav Brain Res       Date:  2001-11-01       Impact factor: 3.332

2.  Differential mechanisms and development of leptin resistance in A/J versus C57BL/6J mice during diet-induced obesity.

Authors:  Veronica Prpic; Patricia M Watson; Isabell C Frampton; Mark A Sabol; G Eric Jezek; Thomas W Gettys
Journal:  Endocrinology       Date:  2003-04       Impact factor: 4.736

3.  High alcohol/sucrose consumption during dark circadian phase in C57BL/6J mice: involvement of hippocampus, lateral septum and urocortin-positive cells of the Edinger-Westphal nucleus.

Authors:  Andrey E Ryabinin; Agustin Galvan-Rosas; Ryan K Bachtell; Fred O Risinger
Journal:  Psychopharmacology (Berl)       Date:  2002-11-20       Impact factor: 4.530

4.  Peripheral ghrelin selectively increases Fos expression in neuropeptide Y - synthesizing neurons in mouse hypothalamic arcuate nucleus.

Authors:  Lixin Wang; David H Saint-Pierre; Yvette Taché
Journal:  Neurosci Lett       Date:  2002-05-31       Impact factor: 3.046

5.  Additive effect of stress and drug cues on reinstatement of ethanol seeking: exacerbation by history of dependence and role of concurrent activation of corticotropin-releasing factor and opioid mechanisms.

Authors:  Xiu Liu; Friedbert Weiss
Journal:  J Neurosci       Date:  2002-09-15       Impact factor: 6.167

6.  CRF1 receptor signaling regulates food and fluid intake in the drinking-in-the-dark model of binge alcohol consumption.

Authors:  William J Giardino; Andrey E Ryabinin
Journal:  Alcohol Clin Exp Res       Date:  2013-02-07       Impact factor: 3.455

7.  Repeated cycles of binge-like ethanol (EtOH)-drinking in male C57BL/6J mice augments subsequent voluntary EtOH intake but not other dependence-like phenotypes.

Authors:  Benjamin R Cox; Jeffrey J Olney; Emily G Lowery-Gionta; Gretchen M Sprow; Jennifer A Rinker; Montserrat Navarro; Thomas L Kash; Todd E Thiele
Journal:  Alcohol Clin Exp Res       Date:  2013-05-03       Impact factor: 3.455

8.  The decreased cellular expression of neuropeptide Y protein in rat brain structures during ethanol withdrawal after chronic ethanol exposure.

Authors:  Adip Roy; Subhash C Pandey
Journal:  Alcohol Clin Exp Res       Date:  2002-06       Impact factor: 3.455

9.  Binge drinking among US adults.

Authors:  Timothy S Naimi; Robert D Brewer; Ali Mokdad; Clark Denny; Mary K Serdula; James S Marks
Journal:  JAMA       Date:  2003-01-01       Impact factor: 56.272

Review 10.  Modeling adolescent development and alcohol use in animals.

Authors:  L Spear
Journal:  Alcohol Res Health       Date:  2000
View more
  92 in total

1.  Anxiety-like behaviors at the end of the nocturnal period in sP rats with a "history" of unpredictable, limited access to alcohol.

Authors:  Giancarlo Colombo; Carla Lobina; Paola Maccioni; Mauro A M Carai; Irene Lorrai; Alessandro Zaru; Andrea Contini; Claudia Mugnaini; Federico Corelli; Gian Luigi Gessa
Journal:  Alcohol       Date:  2015-07-21       Impact factor: 2.405

Review 2.  Genes and Alcohol Consumption: Studies with Mutant Mice.

Authors:  J Mayfield; M A Arends; R A Harris; Y A Blednov
Journal:  Int Rev Neurobiol       Date:  2016       Impact factor: 3.230

3.  The phosphodiesterase-4 inhibitor roflumilast decreases ethanol consumption in C57BL/6J mice.

Authors:  Xin Liu; Pi-Da Hao; Ming-Feng Yang; Jing-Yi Sun; Lei-Lei Mao; Cun-Dong Fan; Zong-Yong Zhang; Da-Wei Li; Xiao-Yi Yang; Bao-Liang Sun; Han-Ting Zhang
Journal:  Psychopharmacology (Berl)       Date:  2017-05-06       Impact factor: 4.530

4.  Lateral hypothalamic melanocortin receptor signaling modulates binge-like ethanol drinking in C57BL/6J mice.

Authors:  Gretchen M Sprow; Jennifer A Rinker; Emily G Lowery-Gointa; Angela M Sparrow; Montserrat Navarro; Todd E Thiele
Journal:  Addict Biol       Date:  2015-05-15       Impact factor: 4.280

5.  Assessment of the Effects of 6 Standard Rodent Diets on Binge-Like and Voluntary Ethanol Consumption in Male C57BL/6J Mice.

Authors:  Simon Alex Marshall; Jennifer A Rinker; Langston K Harrison; Craig A Fletcher; Tina M Herfel; Todd E Thiele
Journal:  Alcohol Clin Exp Res       Date:  2015-06-25       Impact factor: 3.455

6.  Evidence that Melanocortin Receptor Agonist Melanotan-II Synergistically Augments the Ability of Naltrexone to Blunt Binge-Like Ethanol Intake in Male C57BL/6J Mice.

Authors:  Montserrat Navarro; Francisca Carvajal; Jose Manuel Lerma-Cabrera; Inmaculada Cubero; Mitchell J Picker; Todd E Thiele
Journal:  Alcohol Clin Exp Res       Date:  2015-06-24       Impact factor: 3.455

7.  Influence of sex on genetic regulation of "drinking in the dark" alcohol consumption.

Authors:  Lauren A Vanderlinden; Laura M Saba; Beth Bennett; Paula L Hoffman; Boris Tabakoff
Journal:  Mamm Genome       Date:  2015-01-06       Impact factor: 2.957

8.  Increased ethanol drinking in "humanized" mice expressing the mu opioid receptor A118G polymorphism are mediated through sex-specific mechanisms.

Authors:  Angela N Henderson-Redmond; Tammy E Lowe; Xi B Tian; Daniel J Morgan
Journal:  Brain Res Bull       Date:  2017-08-02       Impact factor: 4.077

9.  Gender-Specific Effects of Selection for Drinking in the Dark on the Network Roles of Coding and Noncoding RNAs.

Authors:  Ovidiu Dan Iancu; Alex M Colville; Beth Wilmot; Robert Searles; Priscila Darakjian; Christina Zheng; Shannon McWeeney; Sunita Kawane; John C Crabbe; Pamela Metten; Denesa Oberbeck; Robert Hitzemann
Journal:  Alcohol Clin Exp Res       Date:  2018-06-22       Impact factor: 3.455

Review 10.  Potential of GABAB Receptor Positive Allosteric Modulators in the Treatment of Alcohol Use Disorder.

Authors:  Paola Maccioni; Giancarlo Colombo
Journal:  CNS Drugs       Date:  2019-02       Impact factor: 5.749

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.